What causes PCR (Polymerase Chain Reaction) inhibition in urine samples?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of PCR Inhibition in Urine Samples

Urea is the primary inhibitor of PCR in urine samples, causing inhibition at concentrations above 50 mM, which is particularly problematic in samples from older children and adults compared to neonates due to higher urea concentrations. 1

Major Inhibitory Components in Urine

Chemical Inhibitors

  • Urea: The major inhibitory component that affects PCR at concentrations >50 mM 1
  • Organic acids: Present in urine and can interfere with PCR reactions 2
  • Betaines: While glycine betaine helps bacteria adapt to high osmolarity, other dietary betaines like trigonelline may enhance urea toxicity and affect PCR 2

Organic Substances

  • Humic acid-like substances: These can cause significant RT-PCR inhibition resulting in >3-log10-unit underestimation of viral loads 3
  • Protein-like fractions: Can be concentrated during sample processing 3
  • Organic fractions in 10-100 kDa size range: Particularly suspected to be PCR inhibitors 3

Sample Collection and Processing Factors

Collection Issues

  • Contamination: Improper specimen collection can introduce contaminants that inhibit PCR 4
  • Storage conditions: Urine samples should be processed within 2 hours or refrigerated to prevent degradation and false results 4

Processing Challenges

  • Concentration procedures: Virus concentration methods can co-concentrate organic inhibitory substances 3
  • Recovery rates: Over 60% of inhibitory organics can be recovered in concentrates during processing 3

Prevalence of PCR Inhibition by Sample Type

  • Urine samples: Relatively low inhibition rate of approximately 1.1% 5
  • Cervical swabs: Moderate inhibition rate of about 7% 5
  • Urethral swabs: High inhibition rate of approximately 45% 5

Methods to Eliminate PCR Inhibition

Physical Methods

  • Storage at 4°C: Eliminates inhibition in 86% of specimens 5
  • Freezing at -70°C: Eliminates inhibition in 72% of specimens 5
  • Dialysis or ultrafiltration: Effectively removes inhibitory effects of urine 1

Chemical Methods

  • Dilution: 1:10 dilution (89% effective) or 1:100 dilution (86% effective) after storage at 4°C 5
  • Phenol-chloroform extraction: Most effective method (99% success rate) 5
  • Addition of bovine serum albumin (BSA): Eliminates inhibitory effects in stool samples and may be applicable to urine 6

PCR Optimization

  • Nested primers: Improves sensitivity and specificity 1
  • Modified PCR protocol: Using reduced reactants in the first cycles of a two-stage PCR 1

Clinical Implications

  • PCR inhibition can lead to false negative results, potentially missing important pathogens
  • Understanding the source of inhibition helps in selecting appropriate sample processing methods
  • Proper specimen collection and handling are critical to minimize inhibition
  • For diagnostic purposes, incorporating internal controls is essential to detect inhibition 7

When processing urine samples for PCR testing, it's important to consider these inhibitory factors and implement appropriate mitigation strategies to ensure accurate results.

References

Research

Inhibitors of bacterial growth in urine: what is the role of betaines?

International journal of antimicrobial agents, 1999

Guideline

Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

PCR inhibition in stool samples in relation to age of infants.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.